Effects of thalidomide on Th17, Treg cells and TGF-ß1/Smad3 pathway in a mouse model of systemic sclerosis.
Int J Rheum Dis
; 23(3): 406-419, 2020 Mar.
Article
in En
| MEDLINE
| ID: mdl-31840939
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pulmonary Fibrosis
/
Scleroderma, Systemic
/
Skin
/
Thalidomide
/
T-Lymphocytes, Regulatory
/
Smad3 Protein
/
Transforming Growth Factor beta1
/
Th17 Cells
/
Immunosuppressive Agents
/
Lung
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
Int J Rheum Dis
Year:
2020
Document type:
Article